Literature DB >> 27083480

Grade B pancreatic fistulas do not affect survival after pancreatectomy for pancreatic cancer: A multicenter observational study.

Manabu Kawai1, Yoshiaki Murakami2, Fuyuhiko Motoi3, Masayuki Sho4, Sohei Satoi5, Ippei Matsumoto6, Goro Honda7, Seiko Hirono1, Ken-Ichi Okada1, Michiaki Unno3, Yoshiyuki Nakajima4, Kenichiro Uemura2, A-Hon Kwon5, Takumi Fukumoto6, Masanao Kurata7, Hiroki Yamaue8.   

Abstract

BACKGROUND: Several studies have demonstrated that postoperative complications after pancreatectomy for pancreatic cancer adversely affect survival. The impact on survival of a pancreatic fistula according to the classification of the International Study Group for Pancreatic Surgery has not been fully evaluated. The aim of this multicenter, observational study was to evaluate the impact of pancreatic fistula on pancreatic cancer patients who had undergone pancreatectomy.
METHODS: Between 2001 and 2012, 1,397 patients who underwent pancreatectomy for pancreatic cancer at 7 high-volume centers in Japan were reviewed retrospectively. The impact of pancreatic fistula on survival was evaluated by univariate and multivariate analysis.
RESULTS: Pancreatic fistula occurred in 327 of 1,397 patients (23.4%) and was classified based on the International Study Group for Pancreatic Surgery as follows: grade A in 9.9%, grade B in 10.6%, and grade C in 2.9% of the patients. Median survival time in no fistula/grade A, grade B, and grade C were 23.6, 26.0, and 9.0 months, respectively. There was no significant difference in overall survival between patients with no fistula/grade A and those with grade B (P = .403); in contrast, overall survival in patients with grade C was worse than in patients without grade C (P < .001). The multivariate Cox proportional hazard analysis demonstrated that grade C pancreatic fistula was an independent prognostic factor (hazard ratio 1.59; 95% confidence interval, 1.03-2.45; P = .035).
CONCLUSION: Grade B pancreatic fistula after pancreatectomy does not adversely affect long-term survival, but a grade C pancreatic fistula has a negative impact on long-term survival of patients with pancreatic cancer.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27083480     DOI: 10.1016/j.surg.2016.02.032

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  5 in total

1.  Survival outcome and prognostic factors after pancreatoduodenectomy for distal bile duct carcinoma: a retrospective multicenter study.

Authors:  Ekaterina Petrova; Felix Rückert; Sebastian Zach; YinFeng Shen; Jürgen Weitz; Robert Grützmann; Uwe A Wittel; Frank Makowiec; Ulrich T Hopt; Peter Bronsert; Florian Kühn; Bettina M Rau; Roman E Izrailov; Igor E Khatkov; Hryhoriy Lapshyn; Louisa Bolm; Dirk Bausch; Tobias Keck; Ulrich F Wellner; Gabriel Seifert
Journal:  Langenbecks Arch Surg       Date:  2017-06-13       Impact factor: 3.445

2.  A pooled analysis of en bloc right hemicolectomy with pancreaticoduodenectomy for locally advanced right-sided colon cancer.

Authors:  Debang Li; Xiaoying Si; Tao Wan; Yanming Zhou
Journal:  Int J Colorectal Dis       Date:  2018-03-02       Impact factor: 2.571

3.  Effect of postoperative major complications on prognosis after pancreatectomy for pancreatic cancer: a retrospective review.

Authors:  Yusuke Watanabe; Kazuyoshi Nishihara; Sokichi Matsumoto; Takafumi Okayama; Yuji Abe; Toru Nakano
Journal:  Surg Today       Date:  2016-10-04       Impact factor: 2.549

4.  The prognostic value of modified Glasgow Prognostic Score in pancreatic cancer: a meta-analysis.

Authors:  Huan Zhang; Dianyun Ren; Xin Jin; Heshui Wu
Journal:  Cancer Cell Int       Date:  2020-09-22       Impact factor: 5.722

5.  Usefulness of the MALDI-TOF MS technology with membrane filter protocol for the rapid identification of microorganisms in perioperative drainage fluids of hepatobiliary pancreatic surgery.

Authors:  Kazuyuki Sogawa; Shigetsugu Takano; Takayuki Ishige; Hideyuki Yoshitomi; Shingo Kagawa; Katsunori Furukawa; Tsukasa Takayashiki; Satoshi Kuboki; Fumio Nomura; Masayuki Ohtsuka
Journal:  PLoS One       Date:  2021-02-04       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.